ESTRADOT (oestradiol), Estalis
Continuous and Sequi (oestradiol/
norethisterone acetate) hormone
replacement therapy patches are
now available on the
Pharmaceutical Benefits Scheme as
a first-line treatment for menopause.
The patches are designed to
manage the short term symptoms
associated menopause, and to also
prevent bone density loss in
postmenopausal women who are at
increased risk of future osteoporotic
fractures and are intolerant of, or
contraindicated for, other medicinal
products approved for the prevention
of bone mineral density loss.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.